Jnba Financial Advisors Biogen Inc. Transaction History

Jnba Financial Advisors

$980 Million
Q3 2024

A detailed history of Jnba Financial Advisors transactions in Biogen Inc. stock. As of the latest transaction made, Jnba Financial Advisors holds 1,016 shares of BIIB stock, worth $160,538. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,016

Previous 1,071 5.14%

Holding current value

$160,538

Previous $248,000 20.97%

% of portfolio

0.02%

Previous 0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$189.07 - $236.8 $10,398 - $13,024	-55 Reduced 5.14%	1,016 $196,000
Q1 2024 Apr 26, 2024	SELL	$212.02 - $267.71 $42,616 - $53,809	-201 Reduced 15.8%	1,071 $230,000
Q3 2023 Nov 02, 2023	BUY	$253.3 - $285.89 $48,380 - $54,604	191 Added 17.67%	1,272 $326,000
Q2 2023 Aug 03, 2023	SELL	$275.25 - $318.06 $1,376 - $1,590	-5 Reduced 0.46%	1,081 $307,000
Q2 2022 Jul 22, 2022	SELL	$187.54 - $223.02 $25,317 - $30,107	-135 Reduced 11.06%	1,086 $221,000
Q1 2022 Apr 29, 2022	SELL	$193.77 - $244.14 $4,844 - $6,103	-25 Reduced 2.01%	1,221 $257,000
Q4 2021 Feb 03, 2022	SELL	$223.92 - $287.77 $1,119 - $1,438	-5 Reduced 0.4%	1,246 $299,000
Q2 2021 Aug 04, 2021	SELL	$259.0 - $414.71 $47,915 - $76,721	-185 Reduced 12.88%	1,251 $433,000
Q4 2020 Jan 25, 2021	SELL	$236.26 - $355.63 $15,356 - $23,115	-65 Reduced 4.33%	1,436 $352,000
Q2 2020 Jul 24, 2020	SELL	$258.66 - $342.55 $19,399 - $25,691	-75 Reduced 4.76%	1,501 $402,000
Q1 2020 May 01, 2020	SELL	$268.85 - $341.04 $2,688 - $3,410	-10 Reduced 0.63%	1,576 $499,000
Q3 2019 Nov 01, 2019	SELL	$217.44 - $243.88 $34,572 - $38,776	-159 Reduced 9.11%	1,586 $369,000
Q2 2019 Jul 26, 2019	BUY	$219.29 - $241.72 $96,487 - $106,356	440 Added 33.72%	1,745 $408,000
Q1 2019 May 01, 2019	SELL	$216.71 - $338.96 $5,417 - $8,474	-25 Reduced 1.88%	1,305 $308,000
Q4 2018 Feb 07, 2019	BUY	$278.5 - $352.75 $252,042 - $319,238	905 Added 212.94%	1,330 $400,000
Q3 2018 Nov 01, 2018	SELL	$293.51 - $383.83 $302,315 - $395,344	-1,030 Reduced 70.79%	425 $150,000
Q1 2018 May 07, 2018	SELL	$260.13 - $367.91 $6,503 - $9,197	-25 Reduced 1.69%	1,455 $1.46 Million
Q4 2017 Jan 31, 2018	SELL	$307.64 - $344.58 $4,614 - $5,168	-15 Reduced 1.0%	1,480 $471,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,495	1,495 $406,000

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.

Account

Jnba Financial Advisors Biogen Inc. Transaction History